Towerpoint Wealth LLC bought a new stake in Israel Chemicals Ltd (NYSE:ICL) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 19,255 shares of the basic materials company’s stock, valued at approximately $96,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of ICL. Lindbrook Capital LLC raised its stake in Israel Chemicals by 149.6% during the third quarter. Lindbrook Capital LLC now owns 5,472 shares of the basic materials company’s stock worth $27,000 after acquiring an additional 3,280 shares in the last quarter. Parallel Advisors LLC raised its stake in Israel Chemicals by 126.1% during the third quarter. Parallel Advisors LLC now owns 7,364 shares of the basic materials company’s stock worth $37,000 after acquiring an additional 4,107 shares in the last quarter. Eaton Vance Management acquired a new position in Israel Chemicals during the second quarter worth $58,000. Signaturefd LLC raised its stake in Israel Chemicals by 30.1% during the second quarter. Signaturefd LLC now owns 13,119 shares of the basic materials company’s stock worth $68,000 after acquiring an additional 3,038 shares in the last quarter. Finally, First Trust Advisors LP acquired a new position in Israel Chemicals during the first quarter worth $73,000. Institutional investors and hedge funds own 6.63% of the company’s stock.
Separately, Zacks Investment Research upgraded Israel Chemicals from a “sell” rating to a “hold” rating in a research note on Tuesday, October 29th.
Israel Chemicals (NYSE:ICL) last released its quarterly earnings data on Thursday, November 7th. The basic materials company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01. Israel Chemicals had a return on equity of 14.03% and a net margin of 9.04%. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same period in the prior year, the company posted $0.10 earnings per share. The business’s revenue for the quarter was down 3.4% compared to the same quarter last year. Research analysts expect that Israel Chemicals Ltd will post 0.41 earnings per share for the current year.
Israel Chemicals Profile
Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.
Featured Story: What is an economic bubble?
Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Israel Chemicals Ltd (NYSE:ICL).
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.